Rethinking osteoporosis: Balancing risk and benefit in diagnosis, prevention, and treatment

Authors

Alice Smith, Wake Forest School of Medicine
Brittany Shaw, Wake Forest School of Medicine
Danielle Laliberte, Wake Forest School of Medicine
Jennifer Langston, Wake Forest School of Medicine
Reamer L. Bushardt, Wake Forest School of MedicineFollow

Document Type

Journal Article

Publication Date

8-1-2013

Journal

Journal of the American Academy of Physician Assistants

Volume

26

Issue

8

DOI

10.1097/01.JAA.0000432496.47021.62

Keywords

Bisphosphonates; Bone mineral density; Fracture risk; Non-estrogen; Osteoporosis

Abstract

The standard of care for osteoporosis is changing amid questions about the long-term safety and efficacy of current drugs for preventing and treating osteoporosis. This article provides a guide for evidence-based treatment, but not overtreatment, as well as the selection and duration of available drug therapies. Copyright © 2013 American Academy of Physician Assistants.

APA Citation

Smith, A., Shaw, B., Laliberte, D., Langston, J., & Bushardt, R. (2013). Rethinking osteoporosis: Balancing risk and benefit in diagnosis, prevention, and treatment. Journal of the American Academy of Physician Assistants, 26 (8). http://dx.doi.org/10.1097/01.JAA.0000432496.47021.62